Non-methylated CpG-motifs in bacterial or viral DNA are recognized by TLR9 as foreign. The activation of TLR9 by microbial DNA or synthetic oligonucleotides based on these motifs leads to the induction of innate immune responses. We have compared the subcellular localization of fluorescent versions of TLR9 and TLR4 and found that TLR9 is expressed in the endoplasmic reticulum while TLR4 is expressed on the plasma membrane. Fluorescently tagged bacterial DNA or CpG-DNA was observed to traffic to a tubular lysosomal compartment in human pDCs. In stimulated cells, TLR9 translocated to CpG-DNA or microbial DNA containing structures in the endosome, where TLR9 binds to DNA and initiates signaling.
INTRODUCTION
The innate immune system recognizes the presence of invading micro-organisms by identifying microbial signature molecules as foreign. 1 Toll-like receptors (TLRs) play a pivotal role in defense against pathogenic microorganisms as they interact with microbial molecules and initiate an immune response. 2, 3 TLRs exert signals that cumulatively lead to the destruction of the invading pathogen and are instructive for adaptive immune responses, for example, leading to the production of antibodies. 4 Among the numerous molecular structures that TLRs can sense as foreign are microbial nucleic acids. [5] [6] [7] TLR9 has evolved to recognize non-methylated CpG-dinucleotides, which are more abundant in microbial DNA as compared to mammalian DNA. The stimulatory activity of microbial DNA can be reproduced by synthetic DNA, 5, 8 and different classes (A,B,C) of stimulatory DNA have preferential activity on certain cell types and vary in the quantity and quality of cellular activation. [9] [10] [11] [12] However, it is unclear to what extent secondary and tertiary structures of naturally occurring viral and bacterial nucleic acid influence the type of immunological activation. While most TLRs recognize molecular structures that are normally absent from the host molecule repertoire, such as bacterial lipopolysaccharides, TLR9 principally detects foreign DNA by the absence of a single methyl-group at the 5-carbon position on cytosine of CpG dinucleotides. The number of CpG dinucleotides are suppressed and most cytosines are methylated 13 in mammalian DNA. However, unmethylated CpG dinucleotides are present in the expected frequency in 'CpG-islands', 14 and hence have the theoretical capability of activating TLR9. Demethylation in gene promoter regions regulates transcriptional activity and is important for regulating gene expression. [15] [16] [17] [18] Thus, it is conceivable that under circumstances where mammalian genomic material is released, these 'self' non-methylated CpG motifs could erroneously be detected by TLR9 as foreign and potentially lead to inflammatory pathology.
It has long been noticed that certain systemic inflammatory diseases, such as systemic lupus erythematosus, are associated with the appearance of 'immune-complexes' containing self DNA. [19] [20] [21] Marshak-Rothstein and colleagues demonstrated that the TLR9-MyD88 signaling axis is principally involved in immune activation by self DNA. [22] [23] [24] [25] [26] These observations open the exciting possibility to pharmacologically target the TLR9 signaling axis in order to discover novel therapeutic interventions for auto-immune diseases.
We have used fluorescent chimeric TLR9 constructs and studied the subcellular localization and trafficking behavior in resting and stimulated cells to learn about the mechanisms of TLR9 activation. These studies demonstrated that the trafficking of CpG-rich DNA, followed by the translocation of TLR9 from the ER to the endosome, is a critical component of TLR9 activation. We have further studied the physical interaction between TLR9 and CpG-DNA and found that TLR9 can bind to CpG-DNA.
MATERIALS AND METHODS

Isolation of pDCs and cell culture
Human PBMCs were isolated from healthy donors by Ficoll-Hypaque centrifugation. Plasmacytoid DCs were purified by magnetic bead separation using anti-BDCA-4 coated microbeads (Miltenyi Biotech, Auburn, CA, USA) by the manufacturer's instructions. The pDCs were cultured in RPMI 1640 (BioWhittaker, Walkersville, MD, USA) supplemented with 10% FBS (Hyclone, Logan, UT, USA), 2 mM L-glutamine, 110 µg/ml sodium pyruvate, 10 µg/ml ciprofloxacin (Mediatech, Herndon, VA, USA), and 10 ng/ml IL-3 (Peprotech, Rocky Hill, NJ, USA). HEK cells stably transfected with YFP-tagged TLR4 or 9 were engineered and cultured as described. [29] [30] [31] 
Confocal microscopy
An inverted Leica laser scanning microscope TSC SP2 AOBS was used for confocal microscopic studies. pDCs were cultured for 5 days as described above and grown on sterile glass-bottomed 35-mm tissue-culture dishes (Mattek, Ashland, MA, USA). Cells were incubated with 3 mM CpG-DNA (Bodipy630/650, MWG Biotech, High Point, NC, USA) in complete growth medium. The sequence of the CpG-DNA used was 5′-TCGTCG-TTTTGTCGTTTTGTCGTT-3′. Cells were washed in growth medium and imaged immediately by confocal microscopy at 37°C.
Fluorescent labeling of bacterial DNA inside
Escherichia coli E. coli O111:B4 cells were labeled in two colors. First, the bacteria were transformed with the bacterial expression vector pEYFP (Clontech, Palo Alto, CA, USA) by electroporation (Genepulser electroporator, Biorad, Hercules, CA, USA). Single colonies of ampicillin-resistant transformants were expanded in broth culture and washed in PBS. In a second step, bacterial DNA was labeled by treating YFP-expressing E. coli O111:B4 (10 10 bacteria/ml) with ethidium monoazide (Molecular Probes, Eugene, OR, USA), which can be photolytically coupled to DNA by illumination with light. Bacteria were left alive or were fixed with freshly prepared paraformaldehyde (4%) before the labeling process. The bacteria were incubated in PBS with 50 mM KCl plus 10 µg/ml ethidium monoazide and subjected to UV (325 nm) illumination for 10 min. After four washes with PBS, bacteria were resuspended in 1 ml of PBS and dialyzed against 1 l of PBS containing 100 µg of salmon sperm DNA (Sigma-Aldrich). Flow cytometry was performed to ensure double color labeling of bacteria.
Ligand-precipitation assay
Stable YFP-tagged TLR4-or TLR9-expressing HEK cells were grown on 10-cm dishes and lysed in 137 mM NaCl, 20 mM Tris/HCl pH 7.4, 1 mM EDTA, 0.5% Triton X-100, 25 mM iodoacetamide, protease inhibitor cocktail (Sigma-Aldrich) and 1 mM phenylmethylsulfonyl-fluoride. After microcentrifugation to remove nuclear debris, cleared cell lysates were incubated with 5 µM biotinylated CpG-DNA (MWG Biotech, High Point, NC, USA) together with streptavidin-coated beads (Sigma-Aldrich) and rotated for 1 h at 4°C. As a control, cell lysates were immunoprecipitated with a GFP polyclonal antibody (Molecular Probes) and 40 µl of packed protein A-Sepharose (Amersham Biosciences) at 4°C for 1 h to assess overall protein levels of the chimeric TLRs. Pellets were washed four times in lysis buffer, resolved by SDS-PAGE under reducing conditions, and electrotransferred to nitrocellulose membranes (HyBond C, Amersham Biosciences). After blocking with 5% powdered milk (Difco, Detroit, MI, USA), the membranes were blotted with anti-GFP mAb (clone JL-8, BD-Biosciences Transduction, Franklin Lakes, NJ, USA). The polyclonal and monoclonal anti-GFP antibodies equally recognize GFP or its spectral variants CFP or YFP. The membranes were then incubated with HRP-conjugated anti-mouse antibody and developed on Hyperfilm with the enhanced chemiluminescence HRP substrate system (Amersham Biosciences).
RESULTS AND DISCUSSION
Differential subcellular distribution of TLRs
Although TLRs share structural elements, such as a leucinerich repeat rich N-terminal domain and a C-terminal TIR domain, the subcellular expression appears to fit at least two distinctive patterns. TLR4 and members of the TLR2 family (TLRs 1, 2 and 6) are expressed on the cell surface, while members of the TLR9 family (TLRs 7, 8 and 9) are confined to intracellular compartments. [27] [28] [29] [30] [31] [32] To address the question of spatial and temporal expression of TLRs, we expressed TLRs that were C-terminally fused to variants of GFP in cell lines and primary cells. Using this technology, we were able to visualize and follow the chimeric proteins in living cells at 37°C. Figure  1 demonstrates the different subcellular distribution of fluorescently tagged (YFP) TLR4 and TLR9 in HEK cells. TLR4 was found primarily on the cell surface and in the Golgi apparatus, 30, 31 while TLR9 was absent from the plasma membrane and was found to be confined to a large pool of intracellular membranes in resting cells. 29 Using confocal microscopy and counterstaining with endoplasmic reticulum (ER) marker proteins, we identified these membranes as the ER. 29 We have also found that TLR7 and TLR8 are similarly expressed in the ER of resting cells (Schoenemeyer, Latz and Golenbock, unpublished observations). Chimeric fluorescent TLR9 correctly represented the subcellular distribution of endogenous TLR9 as determined by immunofluorescence in human pDCs. 29 To date, it is unclear by which mechanisms certain TLRs are retained in intracellular compartments. In theory, retention signals could exist that interact with proteins that keep certain TLRs in their predestined compartment. Alternatively, other proteins that carry such signals could interact with the TLRs and indirectly retain them in their given localization.
Mechanisms of TLR9 activation 409
DNA traffics into the tubular lysosomal compartment in antigen presenting cells
In order to stimulate TLR9, DNA needs to enter the cell. We followed the path of fluorescent CpG-rich oligonucleotides in isolated human pDCs in order to determine how cells take up and traffic DNA. We observed that CpG-DNA enters pDCs via early endosomes and later, after about 30 min incubation, traffics into a tubular lysosomal compartment. 29 DNA-positive tubules were observed to be highly motile and exhibited rapid movement from intracellular pools to the plasma membrane (Fig. 2, lower panel) . Recent studies suggest that the tubular lysosomal compartment is involved in antigen processing and peptide loading on MHC molecules. 33, 34 It is largely unknown how immune-stimulatory DNA is processed and potentially modified in the lysosomal environment.
In living micro-organisms, bacterial DNA is not immediately accessible to its cognate receptor. As a result of host defenses, foreign DNA has the potential to be liberated. Bacterial DNA may originate from phagocytosed bacteria and be released from disintegrated bacteria inside the host cellular lysosomal compartment. In order to follow genomic DNA from phagocytosed bacteria, we covalently labeled bacterial DNA in YFP expressing E. coli. This resulted in E. coli cells that fluoresce in two different colors ( Fig. 3) . Labeled bacteria were added to pDCs and allowed to be phagocytosed. After 4 h incubation, living pDCs were imaged by confocal microscopy. DNA was released into tubular structures resembling the structures seen with externally added CpG-DNA (Fig. 3B) . The fluorescence of YFP expressed in these bacteria disappeared after longer incubation times presumably due to the proteolytic degradation of the protein fluorochrome. In contrast, bacterial DNA could not be released from bacteria that were fixed before the labeling of the DNA, indicating that the labeling procedure itself was efficient and that the dye was covalently attached to bacterial DNA (Fig. 3C) . These findings indicate that DNA released from degraded bacteria ultimately is located in tubular structures similar to those identified with fluorescent CpG-DNA. The data further suggest that the mechanisms cells use to recognize CpG-DNA and bacterial DNA are similar.
We next tested fluorescently tagged TLR9 that was expressed in mouse dendritic cells in order to determine how CpG-DNA and TLR9 encounter one another in native cells. We retrovirally transduced mouse dendritic cells with fluorescent TLR9 and incubated the cells with CpG-DNA. We observed that TLR9 rapidly translocated to the site of DNA uptake. Signaling was initiated in these compartments as evidenced by the concomitant recruitment of the adapter molecule MyD88 to these CpG-DNA rich compartments. 29 Ahmad-Nehjad et al. 32 similarly observed that in a mouse macrophage cell line the initiation of LPS and CpG-DNA signaling commences at different subcellular localizations and suggested that TLR9 signaling is initiated in the lysosomal compartment. Together, these findings are in line with the notion that DNA recognition requires functional endosomal maturation, such as the ability to acidify this micro-environment. 35 The exact mechanism by which TLR9 can access the endosomal/lysosomal compartment is still unclear. It appears unlikely that TLR9 enters the lysosomal compartment via the secretory pathway, as we failed to observe carbohydrate modifications on TLR9 that are typical for Golgi-derived enzymatic modifications. 29 Recent evidence suggests that the ER can contribute its membrane to developing phagosomes. 36, 37 During the process termed 'ER-mediated phagocytosis', functional properties are also added from the ER to the phagosome. It was found that by the fusion with the ER, the phagosome acquires all proteins necessary for the process of 'cross-presentation'. [38] [39] [40] [41] It is conceivable that during ER-mediated phagocytosis, TLRs 7-9 could access exogenously internalized viral or bacterial nucleic acids. We propose that not only the process of cross-presentation but also the recognition of nucleic acids by members of the TLR9 family is enabled by the presumed fusion event between the ER and the phagosome.
TLR9 directly binds CpG-DNA
Our visual studies indicated a strong enrichment of fluorescent TLR9 towards the site of CpG-DNA uptake and suggested molecular interaction of TLR9 with CpG-DNA. 29 To test this hypothesis, cellular lysates of HEK cells stably expressing YFP-tagged TLR9 or YFPtagged TLR4 (as a control) were incubated with biotinylated CpG-DNA. Using streptavidin-coated beads, we were able to precipitate TLR9 (as a receptor-ligand complex bound to CpG-biotin), but not TLR4 (Fig. 4A) , indicating a binding event between CpG-DNA and TLR9. The binding of biotinylated CpG-DNA to TLR9 can be competed out by excess non-biotinylated CpG-DNA ( Fig. 4B ) indicating specificity. These results do not exclude an alternative explanation that TLR9 may be part of a larger receptor complex that includes a CpGbinding subunit, and that the receptor complex is precipitated by biotin-CpG-DNA. However, despite intensive efforts, we have yet to determine the presence of additional proteins in the precipitated receptor.
Deciphering the steps and individual mechanisms by which DNA is recognized is of great importance for drug discovery and development. Promising new therapeutic concepts that involve TLR9 agonistic agents are being explored. 8, [42] [43] [44] [45] [46] Additionally, in certain autoimmune diseases, such as systemic lupus erythematosus, blocking of TLR9-mediated signals may prove to be beneficial. In theory, each step from the DNA uptake to the binding to TLR9 is required for TLR9 to recognize DNA. The complicated mode of TLR9 activation opens the potential for several modes of pharmacological modulation. At the same time, however, we need to be prepared for the challenge to be able to assess which molecular mechanisms might be targeted by pharmacological agents. In other words, it is important to design assay systems that can test each step in DNA recognition.
